Use of monoclonal antibodies against epidermal growth factor receptor for treating patients suffering from acute respiratory failure of hypoxemia type

The present invention relates to the fields of biotechnology and medicine and provides the use of monoclonal antibodies against epidermal growth factor receptors in the treatment of infectious diseases resulting in hypoxemia-type acute respiratory failure. 本发明涉及生物技术和医学领域并且提供了针对表皮生长因子受体的单克隆抗体治疗导致低氧血症...

Full description

Saved in:
Bibliographic Details
Main Authors SAAVEDRA HERNANDEZ, DANAI, KROMBERT RAMOS TANIA, RAMOS SUZARTE MEIRA, ROLANDO PEREZ RODRIGUEZ, ARNAY CURRY ANA LAURA, ABDO CUZA ANSELMO ANTONIO, ARMANDA, JORGE, GIMENEZ, KALET LEON MONZON, LONDREZ HENRY DIAZ
Format Patent
LanguageChinese
English
Published 02.02.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the fields of biotechnology and medicine and provides the use of monoclonal antibodies against epidermal growth factor receptors in the treatment of infectious diseases resulting in hypoxemia-type acute respiratory failure. 本发明涉及生物技术和医学领域并且提供了针对表皮生长因子受体的单克隆抗体治疗导致低氧血症型急性呼吸衰竭的传染源疾病的用途。
Bibliography:Application Number: CN202280042158